Effects of Bisphosphonates on Osteoporosis Induced by Duchenne Muscular Dystrophy: A Prospective Study
- 1 December 2020
- journal article
- research article
- Published by Elsevier BV in Endocrine Practice
- Vol. 26 (12), 1477-1485
- https://doi.org/10.4158/ep-2020-0073
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Long-term effects of glucocorticoids on function, quality of life, and survival in patients with Duchenne muscular dystrophy: a prospective cohort studyThe Lancet, 2018
- Diagnosis and management of Duchenne muscular dystrophy, part 2: respiratory, cardiac, bone health, and orthopaedic managementThe Lancet Neurology, 2018
- Current and emerging treatment strategies for Duchenne muscular dystrophyNeuropsychiatric Disease and Treatment, 2016
- Determining the role of skewed X-chromosome inactivation in developing muscle symptoms in carriers of Duchenne muscular dystrophyHuman Genetics, 2016
- Optimizing Bone Health in Duchenne Muscular DystrophyInternational Journal of Endocrinology, 2015
- Exon skipping therapy for Duchenne muscular dystrophyAdvanced Drug Delivery Reviews, 2015
- Newborn bloodspot screening for Duchenne Muscular Dystrophy: 21 years experience in Wales (UK)European Journal of Human Genetics, 2013
- Evidence‐based path to newborn screening for duchenne muscular dystrophyAnnals of Neurology, 2012
- Mechanisms inducing low bone density in duchenne muscular dystrophy in mice and humansJournal of Bone and Mineral Research, 2011
- Survival in Duchenne muscular dystrophy: improvements in life expectancy since 1967 and the impact of home nocturnal ventilationNeuromuscular Disorders, 2002